|
|
Товарное название |
|
|
Trade names are indicative and excipients composition can be different depending on the country and manufacturers
|
Acetaflur |
Мексика |
Asoleudox |
Мексика |
Beneflur |
Испания, Мексика |
Fludabin |
Перу |
Fludacel |
Индия, Перу |
Fludakebir |
Перу |
Fludalym |
Турция |
Fludara |
Австрия, Бельгия, Великобритания, Венгрия, Венесуэла, Германия, Голландия, Дания, Египет, Индия, Иран, Ирландия, Италия, Колумбия, Люксембург, Малайзия, новая Зеландия, Польша, Португалия, Румыния, Саудовская Аравия, Соединённые Штаты Америки, Финляндия, Франция, чили, Швейцария, Швеция |
Fludarabin |
Исландия, Италия, Норвегия, Швейцария, Швеция |
Fludarabina |
Аргентина, Испания, Колумбия, Перу, Румыния |
Fludarabine |
Бельгия, Иран, Канада, новая Зеландия, Норвегия, Соединённые Штаты Америки, Швейцария |
Fludarin |
Индия |
Fludarosa |
Аргентина |
Forclina |
Перу |
Ludabina |
Колумбия, чили |
Mepredin |
Перу |
Naprobin |
Индия |
Neoflubin |
Иран |
|
|
|
|
Библиография : Fludarabine phosphate |
|
|
тип |
публикация |
3 |
Журнал |
Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212. |
81 |
Журнал |
Trissel LA, Martinez JF. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 672-678. |
84 |
Журнал |
Trissel LA, Martinez JF. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 495-499. |
99 |
Журнал |
Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 1086-1090. |
169 |
Журнал |
Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993 ; 50: 2359-2363. |
182 |
Журнал |
Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60. |
244 |
Журнал |
Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913. |
249 |
Журнал |
Trissel LA, Martinez JF. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1996 ; 53: 1041-1045. |
307 |
Журнал |
Trissel LA, Martinez JF. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1792-1799. |
492 |
Журнал |
Trissel LA, Parks NPT, Santiago NM. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 2186-2189. |
905 |
Журнал |
Trissel LA, Martinez JF. Screening teniposide for Y-site physical incompatibilities. Hosp Pharm 1994 ; 29: 1010-1017. |
1410 |
Журнал |
Trissel LA, Martinez JF, Simmons M. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 141-145. |
1423 |
Журнал |
Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518. |
2344 |
Лаборатория |
Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution. Ebewe Pharma 2009 |
3306 |
Журнал |
Trittler R. New stability studies for fludarabine according to the European Pharmacopoeia 7.0 EJOP 2012 ; 6, 1: 1-2. |
3595 |
Лаборатория |
Aciclovir - Summary of Product Characteristics Hospira 2009 |
3604 |
Лаборатория |
Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit Sanofi Aventis France 2012 |
3637 |
Лаборатория |
Methotrexate (Methotrexate solution for injection®) - Summary of Product Characteristics Hameln Pharmaceuticals 2014 |
3644 |
Лаборатория |
Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010 |
3670 |
Журнал |
Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30. |
3838 |
Лаборатория |
Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007 |
4398 |
Журнал |
Smith E. K., Shergold J.A., McWhinney B.C. Compatibility of intravenous busulfan with BBraun giving sets, fludarabine and Posiflush. J Pharm Pract and Res 2020 |
|
|